Clinical implications of neuroendocrine differentiation in prostate cancer

被引：71
|
作者：
Nelson, E. C. [1 ]
Cambio, A. J. [1 ]
Yang, J. C. [1 ]
Ok, J-H [1 ]
Lara, P. N., Jr. [1 ]
Evans, C. P. [1 ]
机构：
[1] Univ Calif Davis, Med Ctr, Dept Urol, Sacramento, CA 95817 USA
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2007年 / 10卷 / 01期
关键词：
androgen-independent prostate cancer; hormone refractory; neuroendocrine cells; neuroendocrine differentiation;
D O I：
10.1038/sj.pcan.4500922
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The cellular signaling pathways of the prostate play a central role in the induction, maintenance, and progression of prostate cancer (CaP). Neuroendocrine ( NE) cells demonstrate attributes that suggest they are an integral part of these signaling cascades. We summarize what is known regarding NE cells in CaP focusing on NE cellular transdifferentiation. This significant event in CaP progression appears to be accelerated by androgen deprivation ( AD) treatment. We examine biochemical pathways that may impact NE differentiation in a chronological manner focusing on AD therapy ( ADT) as a central event in inducing androgen-independent CaP. Our analysis is limited to the common adenocarcinoma pattern of CaP and excludes small-cell and carcinoid prostatic variants. In conclusion, we speculate on the future of treatment and research in this area.
引用
收藏
页码：6 / 14
页数：9
相关论文
共 50 条
  • [21] Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases
    Sciarra, A
    Bosman, C
    Schillaci, O
    Monti, M
    Di Chiro, C
    Di Silverio, F
    BJU INTERNATIONAL, 2001, 87 (01) : 123 - 125
  • [22] Molecular aspects of prostate cancer with neuroendocrine differentiation
    Qi Li
    Connie S.Zhang
    Yifen Zhang
    ChineseJournalofCancerResearch, 2016, 28 (01) : 122 - 129
  • [23] MicroRNA regulators of neuroendocrine differentiation of prostate cancer
    Sreekumar, Amritha
    Saini, Sharanjot
    CANCER RESEARCH, 2023, 83 (11)
  • [24] Prognostic significance of neuroendocrine differentiation in prostate cancer
    Ather, MH
    Abbas, F
    EUROPEAN UROLOGY, 2000, 38 (05) : 535 - 542
  • [25] Key players of neuroendocrine differentiation in prostate cancer
    Santoni, Matteo
    Aurilio, Gaetano
    Maccioni, Alessandro
    Nole, Franco
    Battelli, Nicola
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [26] Molecular aspects of prostate cancer with neuroendocrine differentiation
    Li, Qi
    Zhang, Connie S.
    Zhang, Yifen
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (01) : 122 - 129
  • [27] Value of the detection of neuroendocrine differentiation in prostate cancer
    Kovylina, M. V.
    Prilepskaya, E. A.
    Sergeiko, I. P.
    Moiseenko, T. N.
    Kolantarev, K. B.
    Govorov, A. V.
    Pushkar, D. Yu.
    ONKOUROLOGIYA, 2013, 9 (04): : 43 - 46
  • [28] Immunohistochemical Analysis of Neuroendocrine Differentiation in Prostate Cancer
    Ishida, Eiwa
    Nakamura, Mitsutoshi
    Shimada, Keiji
    Tasaki, Masato
    Konishi, Noboru
    PATHOBIOLOGY, 2009, 76 (01) : 30 - 38
  • [29] Neuroendocrine differentiation in prostate cancer: Is it detectable and treatable?
    Birtle, AJ
    Freeman, A
    Payne, HA
    Masters, JRW
    Harland, SJ
    BJU INTERNATIONAL, 2003, 92 (04) : 490 - 490
  • [30] The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
    Ramnarine, Varune Rohan
    Alshalalfa, Mohammed
    Mo, Fan
    Nabavi, Noushin
    Erho, Nicholas
    Takhar, Mandeep
    Shukin, Robert
    Brahmbhatt, Sonal
    Gawronski, Alexander
    Kobelev, Maxim
    Nouri, Mannan
    Lin, Dong
    Tsai, Harrison
    Lotan, Tamara L.
    Karnes, R. Jefferey
    Rubin, Mark A.
    Zoubeidi, Amina
    Gleave, Martin E.
    Sahinalp, Cenk
    Wyatt, Alexander W.
    Volik, Stanislav V.
    Beltran, Himisha
    Davicioni, Elai
    Wang, Yuzhuo
    Collins, Colin C.
    GIGASCIENCE, 2018, 7 (06):
12345